MetLife Small Cap Core Equity Strategy (S:0P0001I7G3)
21.76
-0.22
(-1.01%)
USD |
Jul 31 2026
Returns Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Key Stats
Basic Info
| Investment Strategy | |
| None |
| General | |
| Security Type | None |
| Equity Style | None |
| Fixed Income Style | None |
| Broad Asset Class | None |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Fund Owner Firm Name | None |
| Broad Asset Class Benchmark Index | |
| None | |
Annual Total Returns Versus Peers
As of September 09, 2026.
Asset Allocation
| Type | % Net |
|---|
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
| Axsome Therapeutics, Inc. | 1.93% | 207.82 | 0.55% |
| Kontoor Brands, Inc. | 1.91% | 70.73 | -3.89% |
| Advanced Energy Industries, Inc. | 1.80% | 288.72 | 2.78% |
| Littelfuse, Inc. | 1.79% | 422.95 | 0.93% |
| Northwest Natural Holding Co. | 1.75% | 49.96 | 1.57% |
| Plexus Corp. | 1.75% | 249.90 | 1.59% |
| State Street SPDR S&P Biotech ETF | 1.71% | 161.93 | -1.15% |
| Praxis Precision Medicines, Inc. | 1.70% | 352.48 | 0.19% |
| iShares Russell 2000 ETF | 1.60% | 294.67 | -0.45% |
| Halozyme Therapeutics, Inc. | 1.59% | 108.31 | -1.71% |
Fees & Availability
| Fees | |
| Negotiable Fee | -- |
| Maximum Management Fee | -- |
| Prospectus Custodian Fee | -- |
| Purchase Details | |
| Open to New Investors | -- |
| Minimum Initial Investment | -- |
| Minimum Subsequent Investment | -- |
Basic Info
| Investment Strategy | |
| None |
| General | |
| Security Type | None |
| Equity Style | None |
| Fixed Income Style | None |
| Broad Asset Class | None |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Fund Owner Firm Name | None |
| Broad Asset Class Benchmark Index | |
| None | |
Fundamentals
| General | |
| Number of Holdings | -- |
| Stock | |
| Weighted Average PE Ratio | -- |
| Weighted Average Price to Sales Ratio | -- |
| Weighted Average Price to Book Ratio | -- |
| Weighted Median ROE | -- |
| Weighted Median ROA | -- |
| Number of Equity Holdings | -- |
Fund Details
| Key Dates | |
| Inception Date | -- |
| Last Annual Report Date | -- |
| Last Prospectus Date | -- |
| Attributes | |
| Index Fund | -- |
| Inverse Fund | -- |
| Leveraged Fund | -- |
| Fund of Funds | -- |
| Currency Hedged Fund | -- |
| Synthetic Replication Fund | -- |
| Socially Responsible Fund | -- |